Randomized Phase II Study of Erlotinib Plus Tivantinib Versus Erlotinib Plus Placebo in Previously Treated Non–Small-Cell Lung Cancer

Lecia V. Sequist, Joan H. Schiller, Wallace Akerley et al.|Journal of Clinical Oncology|2011

Cited by 379